Pembrolizumab biosimilar (Hetero Biopharma)
帕博利珠单抗生物类似药（Hetero Biopharma）
Report date: 2025/02/18 10:49:59
Base Information
Drug NamePembrolizumab biosimilar (Hetero Biopharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHetero Biopharma Ltd
China Registration ClassN/A
Develop Information
Active CompaniesHetero Biopharma Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A